Source comparison
Tesamorelin + Ipamorelin Blend for Women: Peptide Stack Comparison
Before committing to any peptide protocol, understanding how the tesamorelin + ipamorelin blend for women compares to alternatives clarifies whether this stack matches your metabolic goals or if another combination serves better. Tesamorelin + Ipamorelin GHRH
This comparison does not assign a generated winner or score.
- Before committing to any peptide protocol, understanding how the tesamorelin + ipamorelin blend for women compares to alternatives clarifies whether this stack matches your metabolic goals or if another combination serves better.
- Tesamorelin + Ipamorelin
- GHRH receptor + ghrelin receptor dual activation
- High—tesamorelin targets VAT preferentially; ipamorelin amplifies lipolysis
- Minimal—ipamorelin does not elevate cortisol
- Tesamorelin 1×/day; ipamorelin 2–3×/day
- Best for women over 35 targeting visceral fat with minimal hormonal disruption; synergistic GH pulse amplitude
- CJC-1295 (no DAC) + Ipamorelin
- GHRH analog + ghrelin receptor agonist
- Moderate—less VAT-selective than tesamorelin
- Minimal
- Both 2–3×/day
- Effective for general fat loss and lean mass; requires more frequent dosing; less clinical data on VAT reduction
- Sermorelin + GHRP-2
- GHRH analog + early-gen secretagogue
- Low—broad fat reduction, not VAT-specific
- Moderate—GHRP-2 elevates cortisol and prolactin
- Older stack with documented appetite increase and cortisol effects; less favorable for cortisol-sensitive women
- Tesamorelin monotherapy
- GHRH receptor activation only
- High—documented 15.2% VAT reduction in TRIM study
- 1×/day
- Simpler protocol but lower GH pulse amplitude versus dual-axis stacks; ideal for compliance-focused users
- Ipamorelin monotherapy
- Ghrelin receptor agonist only
- Low—general lipolysis without VAT targeting
- 2–3×/day
- Supports lean mass and recovery; less effective for stubborn visceral fat versus tesamorelin combinations
- The tesamorelin + ipamorelin blend for women offers the highest specificity for visceral adipose reduction among commonly researched peptide stacks, with the added benefit of cortisol-neutral GH amplification—critical for women dealing with stress-driven fat accumulation or hormonal sensitivity during perimenopause.